Suppr超能文献

补充水溶性维生素可降低高血压前期患者的高同型半胱氨酸血症、胰岛素抵抗及高敏C反应蛋白水平。

Supplementation of Water-Soluble Vitamins Reduces Hyperhomocysteinemia, Insulin Resistance, and High-Sensitivity C-reactive Protein in Prehypertension Subjects.

作者信息

Talikoti Prashanth, Bobby Zachariah, Hamide Abdoul

机构信息

Biochemistry, Employees' State Insurance Corporation (ESIC) Medical College, Gulbarga, IND.

Biochemistry, Jawaharlal Institute of Postgraduate Medical Education and Research, Puducherry, IND.

出版信息

Cureus. 2023 Jan 7;15(1):e33481. doi: 10.7759/cureus.33481. eCollection 2023 Jan.

Abstract

BACKGROUND

Prehypertensives are at higher risk of developing cardiovascular diseases. Hyperhomocysteinemia, insulin resistance, and increased high-sensitivity C-reactive protein (hs-CRP) are independent risk factors for the development of cardiovascular complications. In prehypertensives, specific therapeutic approaches can be implemented at the earliest to prevent the onset of overt hypertension. So the present study was performed to study the effect of supplementation of water-soluble vitamins on cardiovascular risk factors like homocysteine, insulin resistance, and C-reactive protein in prehypertensive subjects.

METHODS

Sixty prehypertensive subjects were recruited into the study based on inclusion and exclusion criteria and randomized into two groups of 30 each. One group was given a placebo and the other was given water-soluble vitamins for four months. Serum homocysteine, insulin, homeostatic model assessment of insulin resistance (HOMA-IR), and hs-CRP were assayed.

RESULTS

After four months of treatment with water-soluble vitamins, there was a significant decrease in levels of serum homocysteine, hs-CRP, and HOMA-IR when compared to placebo treatment. After four months of treatment, there was a significant decrease in the levels of hs-CRP, homocysteine, and HOMA-IR in groups treated with water-soluble vitamins compared to the basal levels.

CONCLUSION

In subjects with prehypertension, supplementation of water-soluble vitamins decreases the level of homocysteine, insulin resistance, and hs-CRP.

摘要

背景

血压正常高值者患心血管疾病的风险更高。高同型半胱氨酸血症、胰岛素抵抗以及高敏C反应蛋白(hs-CRP)升高是心血管并发症发生的独立危险因素。对于血压正常高值者,可尽早采取特定治疗方法以预防显性高血压的发生。因此,本研究旨在探讨补充水溶性维生素对血压正常高值者同型半胱氨酸、胰岛素抵抗及C反应蛋白等心血管危险因素的影响。

方法

根据纳入和排除标准,招募60名血压正常高值者进入研究,并随机分为两组,每组30人。一组给予安慰剂,另一组给予水溶性维生素,为期四个月。检测血清同型半胱氨酸、胰岛素、胰岛素抵抗稳态模型评估(HOMA-IR)及hs-CRP。

结果

与安慰剂治疗相比,水溶性维生素治疗四个月后,血清同型半胱氨酸、hs-CRP及HOMA-IR水平显著降低。治疗四个月后,与基础水平相比,接受水溶性维生素治疗组的hs-CRP、同型半胱氨酸及HOMA-IR水平显著降低。

结论

在血压正常高值者中,补充水溶性维生素可降低同型半胱氨酸水平、胰岛素抵抗及hs-CRP。

相似文献

本文引用的文献

9
Pre-hypertension: Is it an inflammatory state?高血压前期:它是一种炎症状态吗?
Clin Chim Acta. 2015 Dec 7;451(Pt B):338-42. doi: 10.1016/j.cca.2015.10.022. Epub 2015 Oct 23.

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验